# Magnesium Sulphate and Rocuronium in Patients Over 60

> **NCT01804205** · PHASE1 · COMPLETED · sponsor: **Pedro Rotava** · enrollment: 64 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01804205
- **Lead sponsor:** Pedro Rotava
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2018-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01804205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01804205, "Magnesium Sulphate and Rocuronium in Patients Over 60". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01804205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*